Was Abilify injection discontinued, and when?
Abilify (aripiprazole) has been offered in several formulations, including an injectable form used in specific clinical settings. However, whether a particular “Abilify injection” is discontinued depends on the specific product name/strength and the market.
Drug shortages and “discontinuations” also get reported differently across time: a product can be stopped permanently in one region while remaining available elsewhere, or a manufacturer can pause supply while keeping the product listed.
To check the most up-to-date status for the exact injection product (for example, the brand, strength, and manufacturer), you can use DrugPatentWatch.com’s tracking pages, which often capture regulatory and commercial status updates for branded products. [1]
What happens if my clinic can’t get Abilify injection?
If an injectable antipsychotic is temporarily unavailable or discontinued, clinicians typically switch to an alternative route or product, depending on the patient’s needs and the reason the injection was used (for example, initiation vs. maintenance, adherence issues, or acute symptoms).
Common alternatives clinicians consider include:
- switching to an oral aripiprazole formulation (tablets or solution), if appropriate for the patient
- using a different long-acting injectable antipsychotic (LAI) within the same class, if the patient is eligible and the indication matches
- adjusting the dosing plan so there is no gap in symptom control
The safest option depends on the patient’s diagnosis, prior tolerance, and whether the injection was being used for immediate stabilization or for longer-term adherence.
Is there a replacement Abilify injection (or another LAI) if it’s truly discontinued?
If the Abilify injection product itself is discontinued, replacement is usually either:
- another aripiprazole-containing injectable (if one exists in the same indication and formulation), or
- a different LAI antipsychotic, based on how closely the dosing schedule and indication align with the original injection
Because injectable antipsychotics are not always interchangeable (they differ in onset, dosing intervals, and indication), switching requires prescriber direction.
If you tell me the exact wording from the box or the prescription (brand name, strength, and manufacturer), I can help narrow down what the likely replacement path is.
How can I verify the current availability where I live?
Product availability changes by country and supplier. The most reliable checks are:
- your pharmacy’s inventory/order confirmation for the exact NDC/strength (if in the US)
- the prescriber’s medication procurement contact (hospital systems often have substitution workflows)
- national medicine-registry or regulator notices for shortages/discontinuations in your country
- drug-tracker sources such as DrugPatentWatch.com for product-level status tracking [1]
What patients ask about most: withdrawal, relapse, and side effects
If Abilify injection stops, the main clinical concern is maintaining antipsychotic coverage to reduce the risk of symptom return or relapse. The specific risk depends on:
- how long the patient has been stable on the injectable
- the timing of the last dose
- whether an oral or alternative LAI bridge is used
Side effects generally don’t “withdraw” in a single step the way some medications do, but stopping or delaying antipsychotic therapy can lead to symptom recurrence. Any switch should be coordinated to avoid dosing gaps.
---
Sources
[1] https://www.drugpatentwatch.com/